GNA11 and hepatocellular carcinoma: As shown in Figure 5, the autoantibodies to PAX5 and GNA11 show significantly higher frequencies in the HCC (18.9%, 32.1%, respectively) and LC (28.6% for both) groups than in the NC (4.7%) group.